BioSpace News Archive

Government

Trump’s HHS pick, Robert F. Kennedy Jr., is an anti-vaccine campaigner who has previously said that he plans to gut the FDA on allegations of corruption and reduce the NIH’s headcount.

November 15, 2024

·

3 min read

·

Tristan Manalac

Pictured: Bristol Myers Squibb office in California

Legal

Celgene Shareholders Hit BMS with Fresh Lawsuit for Allegedly Dodging CVR Payments

BMS has so far been on a winning streak in the contingent value right cases, which allege that the pharma intentionally delayed regulatory activities for Breyanzi in order to avoid a $6.4 billion payout to Celgene shareholders.

November 15, 2024

·

2 min read

·

Tristan Manalac

Contemporary art collage. Conceptual image. Businessman catching money given by a hand. In search of profit. Concept of business, economy, financial growth, promotion, following

Earnings

Bluebird Faces Cash Gap With Breakeven Point in Sight

Bluebird has just two quarters until it’s out of cash. Executives are looking for financing to extend that runway to a projected breakeven point before the end of 2025, with analysts worried they won’t make it.

November 15, 2024

·

4 min read

·

Annalee Armstrong

Creative process. Pop art collage. Female hand typing on retro typewriter isolated over white background. Vintage, retro 80s, 70s style. Bright colors. Copy space for ad, text

Editorial

Pharma’s Q3 Was a Rollercoaster Ride. Let’s Do It Again Next Quarter

Big Pharma had plenty of drama to keep journalists busy this quarter, which painted an accurate portrait of the wild and wonderful world of biopharma.

November 15, 2024

·

3 min read

·

Annalee Armstrong

Group Of Employees Being Fired By Their Company.

Layoffs

Gilead and Kite Are Cutting Employees, Closing Seattle, Philadelphia Sites

Gilead’s layoffs include 72 employees at its Seattle location, which will close. Kite will shut down its Philadelphia facility. The layoffs are attributed to aligning resources with long-term strategic goals.

November 15, 2024

·

2 min read

·

Angela Gabriel

Recession arrow, Graph showing business decline on led screen

Drug Development

Eyenovia Shares Plummet 70% After It Drops Lead Program

Eyenovia’s stock craters to its lowest point in its six-year lifespan as a public company following the biotech’s termination of its lead program in pediatric progressive myopia due to lack of efficacy.

November 15, 2024

·

2 min read

·

Heather McKenzie

Press Releases

Shattuck Labs Reports Third Quarter 2024 Financial Results and Recent Business Highlights

November 15, 2024

·

8 min read

Press Releases

Nuvectis Pharma Reports Encouraging NXP800 Interim Data Supporting Ongoing Enrollment in Phase 1b Study in Patients with Platinum-Resistant ARID1a-Mutated Ovarian Cancer